feed icon

Caldolor does the trick

Posted on October 19, 2009 at 2:32 pm

Cumberland Pharmaceuticals said today that the results of a Phase III study of Caldolor, its intravenous ibuprofen, show patients getting 800 mg of the drug every six hours after orthopedic and abdominal surgery need fewer narcotics and have less pain than those receiving only morphine. The company’s stock (Ticker: CPIX) is headed into the close up nearly 5 percent on the news.

Comments

Leave a Reply




Recent Comments

The Conglomerate